Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pacemaker, Artificial | 13 | 2021 | 828 | 1.520 |
Why?
|
Tachycardia, Supraventricular | 13 | 2023 | 273 | 1.440 |
Why?
|
Tachycardia, Ventricular | 15 | 2022 | 1309 | 1.300 |
Why?
|
Electrocardiography | 35 | 2024 | 6409 | 1.290 |
Why?
|
Catheter Ablation | 23 | 2024 | 2776 | 1.280 |
Why?
|
Heart Defects, Congenital | 28 | 2023 | 4713 | 1.260 |
Why?
|
Cardiac Pacing, Artificial | 12 | 2016 | 881 | 1.250 |
Why?
|
Arrhythmias, Cardiac | 13 | 2022 | 2258 | 1.140 |
Why?
|
Atrioventricular Block | 5 | 2022 | 141 | 1.090 |
Why?
|
Defibrillators, Implantable | 11 | 2022 | 1498 | 1.060 |
Why?
|
Heart Block | 10 | 2022 | 390 | 1.010 |
Why?
|
Accessory Atrioventricular Bundle | 6 | 2023 | 58 | 0.940 |
Why?
|
Syncope | 7 | 2019 | 430 | 0.890 |
Why?
|
Long QT Syndrome | 7 | 2017 | 472 | 0.890 |
Why?
|
Electric Countershock | 8 | 2023 | 534 | 0.850 |
Why?
|
Death, Sudden, Cardiac | 9 | 2014 | 1568 | 0.830 |
Why?
|
Fontan Procedure | 7 | 2018 | 805 | 0.690 |
Why?
|
Exercise Test | 6 | 2022 | 2186 | 0.670 |
Why?
|
Echocardiography | 14 | 2024 | 5044 | 0.650 |
Why?
|
Heart Ventricles | 7 | 2024 | 3838 | 0.620 |
Why?
|
Heart Neoplasms | 2 | 2019 | 374 | 0.570 |
Why?
|
Wolff-Parkinson-White Syndrome | 4 | 2023 | 117 | 0.550 |
Why?
|
Tachycardia, Atrioventricular Nodal Reentry | 5 | 2024 | 148 | 0.530 |
Why?
|
Ventricular Fibrillation | 5 | 2022 | 537 | 0.530 |
Why?
|
Electrophysiologic Techniques, Cardiac | 8 | 2024 | 511 | 0.510 |
Why?
|
Child | 86 | 2024 | 80891 | 0.510 |
Why?
|
Heart Arrest | 3 | 2022 | 1516 | 0.500 |
Why?
|
Radio Waves | 1 | 2016 | 254 | 0.490 |
Why?
|
Bandages | 1 | 2016 | 273 | 0.470 |
Why?
|
Adolescent | 82 | 2024 | 89184 | 0.470 |
Why?
|
Equipment Failure | 7 | 2014 | 585 | 0.470 |
Why?
|
Heart Diseases | 7 | 2013 | 2819 | 0.450 |
Why?
|
Child, Preschool | 52 | 2024 | 42650 | 0.430 |
Why?
|
Central Nervous System Stimulants | 4 | 2015 | 1181 | 0.410 |
Why?
|
Tachycardia | 3 | 2023 | 598 | 0.400 |
Why?
|
Foreign Bodies | 1 | 2016 | 403 | 0.400 |
Why?
|
Heart Conduction System | 7 | 2021 | 1009 | 0.390 |
Why?
|
Cardiomyopathy, Hypertrophic | 6 | 2022 | 1335 | 0.370 |
Why?
|
Syndactyly | 2 | 2014 | 75 | 0.360 |
Why?
|
Heart Septum | 4 | 2019 | 304 | 0.360 |
Why?
|
Anti-Arrhythmia Agents | 6 | 2023 | 775 | 0.360 |
Why?
|
Lyme Disease | 3 | 2021 | 630 | 0.350 |
Why?
|
Infant | 35 | 2024 | 36510 | 0.340 |
Why?
|
Retrospective Studies | 55 | 2024 | 81801 | 0.340 |
Why?
|
Cardiac Resynchronization Therapy | 4 | 2018 | 559 | 0.330 |
Why?
|
Electrocardiography, Ambulatory | 3 | 2020 | 579 | 0.330 |
Why?
|
Sotalol | 2 | 2020 | 47 | 0.330 |
Why?
|
Heart Valve Prosthesis | 1 | 2017 | 1468 | 0.310 |
Why?
|
Myocardium | 2 | 2019 | 4788 | 0.300 |
Why?
|
Atrial Flutter | 3 | 2023 | 253 | 0.290 |
Why?
|
Bundle-Branch Block | 3 | 2018 | 278 | 0.290 |
Why?
|
Myocarditis | 4 | 2021 | 803 | 0.280 |
Why?
|
Aortic Valve | 1 | 2017 | 1969 | 0.280 |
Why?
|
Ebstein Anomaly | 2 | 2021 | 106 | 0.280 |
Why?
|
Primary Prevention | 1 | 2014 | 1187 | 0.270 |
Why?
|
Transposition of Great Vessels | 3 | 2015 | 580 | 0.270 |
Why?
|
Ventricular Dysfunction, Left | 6 | 2024 | 2144 | 0.260 |
Why?
|
Rest | 1 | 2011 | 951 | 0.260 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 5 | 2015 | 3743 | 0.260 |
Why?
|
Chest Pain | 1 | 2013 | 1099 | 0.260 |
Why?
|
Humans | 121 | 2024 | 768393 | 0.260 |
Why?
|
Dizziness | 1 | 2008 | 269 | 0.250 |
Why?
|
Cardiac Surgical Procedures | 5 | 2016 | 3681 | 0.250 |
Why?
|
Young Adult | 38 | 2024 | 60049 | 0.250 |
Why?
|
Craniopharyngioma | 1 | 2008 | 279 | 0.250 |
Why?
|
Female | 87 | 2024 | 397089 | 0.240 |
Why?
|
Fluoroscopy | 3 | 2022 | 952 | 0.230 |
Why?
|
Exercise | 3 | 2022 | 5946 | 0.230 |
Why?
|
Borrelia burgdorferi | 1 | 2006 | 183 | 0.230 |
Why?
|
Male | 86 | 2024 | 364902 | 0.230 |
Why?
|
Exercise Therapy | 2 | 2022 | 941 | 0.230 |
Why?
|
Risk Assessment | 16 | 2022 | 24318 | 0.230 |
Why?
|
Electrodes, Implanted | 5 | 2010 | 841 | 0.230 |
Why?
|
Malnutrition | 1 | 2010 | 631 | 0.220 |
Why?
|
Pre-Excitation Syndromes | 2 | 2021 | 27 | 0.220 |
Why?
|
Autonomic Nervous System | 1 | 2008 | 709 | 0.220 |
Why?
|
Tachycardia, Ectopic Atrial | 3 | 2011 | 65 | 0.220 |
Why?
|
Fetal Diseases | 3 | 2020 | 916 | 0.210 |
Why?
|
Ventricular Septum | 1 | 2023 | 76 | 0.210 |
Why?
|
Aortic Diseases | 1 | 2008 | 741 | 0.200 |
Why?
|
Boston | 15 | 2020 | 9371 | 0.200 |
Why?
|
Abdominal Pain | 1 | 2008 | 1070 | 0.200 |
Why?
|
Heart Rate | 10 | 2020 | 4218 | 0.200 |
Why?
|
Aorta, Thoracic | 1 | 2008 | 1112 | 0.200 |
Why?
|
Ventricular Function, Left | 5 | 2018 | 3941 | 0.190 |
Why?
|
Oxygen Consumption | 4 | 2023 | 1882 | 0.190 |
Why?
|
Oxyhemoglobins | 1 | 2022 | 213 | 0.190 |
Why?
|
Anorexia Nervosa | 1 | 2010 | 1364 | 0.180 |
Why?
|
Steroids | 1 | 2005 | 937 | 0.170 |
Why?
|
Tetralogy of Fallot | 5 | 2013 | 628 | 0.170 |
Why?
|
Infant, Newborn | 18 | 2022 | 26411 | 0.170 |
Why?
|
Treatment Outcome | 33 | 2022 | 65379 | 0.170 |
Why?
|
Technology | 1 | 2022 | 296 | 0.170 |
Why?
|
Heart Rate, Fetal | 1 | 2020 | 76 | 0.170 |
Why?
|
Pituitary Neoplasms | 1 | 2008 | 1325 | 0.160 |
Why?
|
Heart | 2 | 2010 | 4449 | 0.160 |
Why?
|
Adult | 45 | 2024 | 223640 | 0.160 |
Why?
|
Procainamide | 1 | 2018 | 56 | 0.160 |
Why?
|
Physical Fitness | 1 | 2023 | 744 | 0.160 |
Why?
|
Reference Values | 2 | 2024 | 4941 | 0.160 |
Why?
|
Organ Size | 1 | 2024 | 2268 | 0.160 |
Why?
|
Myocardial Revascularization | 1 | 2002 | 796 | 0.150 |
Why?
|
Fetal Heart | 1 | 2020 | 281 | 0.150 |
Why?
|
Recurrence | 9 | 2022 | 8506 | 0.150 |
Why?
|
Risk Factors | 24 | 2020 | 74962 | 0.150 |
Why?
|
Atrial Fibrillation | 4 | 2023 | 5168 | 0.150 |
Why?
|
Body Surface Potential Mapping | 3 | 2024 | 228 | 0.140 |
Why?
|
Amiodarone | 1 | 2018 | 217 | 0.140 |
Why?
|
Hospitalization | 3 | 2021 | 10844 | 0.140 |
Why?
|
Stroke Volume | 4 | 2024 | 5619 | 0.130 |
Why?
|
Incidence | 10 | 2020 | 21544 | 0.130 |
Why?
|
Time Factors | 11 | 2020 | 40272 | 0.130 |
Why?
|
Cardiac Output | 1 | 2018 | 838 | 0.130 |
Why?
|
Regional Health Planning | 1 | 2016 | 96 | 0.130 |
Why?
|
Saxitoxin | 1 | 2015 | 65 | 0.130 |
Why?
|
Models, Statistical | 1 | 2010 | 5099 | 0.120 |
Why?
|
Sports | 2 | 2020 | 703 | 0.120 |
Why?
|
Punctures | 2 | 2013 | 372 | 0.120 |
Why?
|
Heart Bypass, Right | 1 | 2015 | 75 | 0.120 |
Why?
|
Follow-Up Studies | 19 | 2022 | 39407 | 0.120 |
Why?
|
Statistics, Nonparametric | 4 | 2012 | 2862 | 0.120 |
Why?
|
Social Class | 1 | 2023 | 2009 | 0.120 |
Why?
|
Heart Atria | 3 | 2016 | 1360 | 0.110 |
Why?
|
Tendons | 1 | 2018 | 559 | 0.110 |
Why?
|
Anesthesia, General | 2 | 2022 | 1186 | 0.110 |
Why?
|
Survival Analysis | 6 | 2011 | 10117 | 0.110 |
Why?
|
Radiation Dosage | 2 | 2013 | 1974 | 0.110 |
Why?
|
Survival Rate | 8 | 2014 | 12870 | 0.110 |
Why?
|
Telemetry | 2 | 2020 | 200 | 0.110 |
Why?
|
Myocardial Contraction | 1 | 2018 | 1527 | 0.110 |
Why?
|
Anesthesia, Local | 1 | 2015 | 279 | 0.110 |
Why?
|
Proportional Hazards Models | 6 | 2014 | 12558 | 0.110 |
Why?
|
Mass Screening | 4 | 2012 | 5451 | 0.110 |
Why?
|
Patient Selection | 2 | 2015 | 4266 | 0.100 |
Why?
|
Cardiovascular Diseases | 2 | 2016 | 15649 | 0.100 |
Why?
|
Rett Syndrome | 1 | 2014 | 164 | 0.100 |
Why?
|
Monitoring, Physiologic | 2 | 2018 | 1795 | 0.100 |
Why?
|
Critical Pathways | 1 | 2016 | 476 | 0.100 |
Why?
|
Pulmonary Valve Insufficiency | 1 | 2013 | 140 | 0.100 |
Why?
|
Bupivacaine | 1 | 2015 | 412 | 0.100 |
Why?
|
Bradycardia | 1 | 2014 | 305 | 0.100 |
Why?
|
Epinephrine | 1 | 2015 | 794 | 0.100 |
Why?
|
Predictive Value of Tests | 9 | 2020 | 15455 | 0.100 |
Why?
|
Isolated Noncompaction of the Ventricular Myocardium | 1 | 2011 | 22 | 0.100 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2012 | 138 | 0.100 |
Why?
|
Eligibility Determination | 1 | 2015 | 421 | 0.090 |
Why?
|
Uncertainty | 1 | 2016 | 759 | 0.090 |
Why?
|
Amphetamines | 1 | 2012 | 143 | 0.090 |
Why?
|
Costello Syndrome | 1 | 2011 | 19 | 0.090 |
Why?
|
Ventricular Function, Right | 1 | 2015 | 628 | 0.090 |
Why?
|
Hemodynamics | 3 | 2016 | 4199 | 0.090 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2016 | 595 | 0.090 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2013 | 477 | 0.090 |
Why?
|
Emergency Service, Hospital | 3 | 2021 | 7955 | 0.090 |
Why?
|
Postoperative Complications | 3 | 2013 | 15881 | 0.090 |
Why?
|
Age Factors | 8 | 2018 | 18471 | 0.090 |
Why?
|
Prevalence | 8 | 2022 | 15872 | 0.090 |
Why?
|
Cardiovascular Abnormalities | 1 | 2011 | 148 | 0.090 |
Why?
|
Equipment Failure Analysis | 2 | 2009 | 848 | 0.080 |
Why?
|
Pulmonary Valve | 1 | 2013 | 413 | 0.080 |
Why?
|
Heart Function Tests | 1 | 2010 | 318 | 0.080 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2015 | 644 | 0.080 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7861 | 0.080 |
Why?
|
Cardiology | 2 | 2016 | 1701 | 0.080 |
Why?
|
Sick Sinus Syndrome | 1 | 2009 | 51 | 0.080 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2015 | 843 | 0.080 |
Why?
|
Cohort Studies | 11 | 2022 | 41795 | 0.080 |
Why?
|
Transplantation, Homologous | 1 | 2017 | 4834 | 0.080 |
Why?
|
Physical Exertion | 1 | 2011 | 669 | 0.080 |
Why?
|
Activities of Daily Living | 1 | 2017 | 2433 | 0.070 |
Why?
|
Friedreich Ataxia | 1 | 2008 | 82 | 0.070 |
Why?
|
Heart Failure | 5 | 2015 | 11858 | 0.070 |
Why?
|
Methylphenidate | 1 | 2012 | 491 | 0.070 |
Why?
|
Troponin T | 1 | 2012 | 787 | 0.070 |
Why?
|
Prosthesis Design | 1 | 2014 | 2126 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2021 | 3801 | 0.070 |
Why?
|
Prostheses and Implants | 2 | 2019 | 1279 | 0.070 |
Why?
|
Dilatation, Pathologic | 1 | 2008 | 527 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1658 | 0.070 |
Why?
|
Endosonography | 1 | 2010 | 622 | 0.070 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2018 | 1496 | 0.070 |
Why?
|
Ventricular Function | 1 | 2008 | 406 | 0.070 |
Why?
|
Electromagnetic Fields | 1 | 2008 | 290 | 0.070 |
Why?
|
Systole | 2 | 2005 | 937 | 0.070 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2014 | 1943 | 0.070 |
Why?
|
Tilt-Table Test | 1 | 2006 | 80 | 0.060 |
Why?
|
Computers, Handheld | 1 | 2008 | 211 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2011 | 1246 | 0.060 |
Why?
|
Abnormalities, Multiple | 1 | 2013 | 1424 | 0.060 |
Why?
|
Radiography, Interventional | 1 | 2013 | 1131 | 0.060 |
Why?
|
Sensitivity and Specificity | 6 | 2013 | 14737 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2016 | 2006 | 0.060 |
Why?
|
Pain | 2 | 2022 | 5103 | 0.060 |
Why?
|
ras Proteins | 1 | 2011 | 1058 | 0.060 |
Why?
|
Comorbidity | 5 | 2013 | 10588 | 0.060 |
Why?
|
Surgery, Computer-Assisted | 1 | 2013 | 1006 | 0.060 |
Why?
|
Device Removal | 1 | 2010 | 643 | 0.060 |
Why?
|
Axillary Vein | 1 | 2004 | 14 | 0.060 |
Why?
|
Autistic Disorder | 1 | 2014 | 1240 | 0.060 |
Why?
|
Diagnosis, Differential | 3 | 2021 | 13020 | 0.060 |
Why?
|
Subclavian Vein | 1 | 2004 | 57 | 0.060 |
Why?
|
Practice Guidelines as Topic | 4 | 2016 | 7453 | 0.060 |
Why?
|
Prosthesis Implantation | 1 | 2009 | 594 | 0.060 |
Why?
|
Coronary Vessels | 2 | 2006 | 3125 | 0.060 |
Why?
|
Complex Regional Pain Syndromes | 1 | 2006 | 122 | 0.060 |
Why?
|
Syncope, Vasovagal | 1 | 2004 | 39 | 0.060 |
Why?
|
Posture | 1 | 2008 | 956 | 0.060 |
Why?
|
Chi-Square Distribution | 2 | 2011 | 3438 | 0.060 |
Why?
|
Calcium Channels, L-Type | 1 | 2005 | 242 | 0.060 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2010 | 1244 | 0.060 |
Why?
|
Propafenone | 1 | 2023 | 27 | 0.060 |
Why?
|
MAP Kinase Signaling System | 1 | 2011 | 1493 | 0.060 |
Why?
|
Disease Management | 1 | 2014 | 2537 | 0.060 |
Why?
|
Prospective Studies | 10 | 2021 | 54920 | 0.050 |
Why?
|
Flecainide | 1 | 2023 | 41 | 0.050 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2007 | 362 | 0.050 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2006 | 268 | 0.050 |
Why?
|
Bundle of His | 1 | 2023 | 102 | 0.050 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2013 | 1568 | 0.050 |
Why?
|
Logistic Models | 3 | 2009 | 13323 | 0.050 |
Why?
|
Pediatrics | 2 | 2016 | 3624 | 0.050 |
Why?
|
Information Storage and Retrieval | 1 | 2008 | 824 | 0.050 |
Why?
|
Inpatients | 1 | 2013 | 2570 | 0.050 |
Why?
|
Athletic Injuries | 1 | 2012 | 1245 | 0.050 |
Why?
|
Cardiomyopathies | 2 | 2011 | 2056 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8753 | 0.050 |
Why?
|
Antipsychotic Agents | 1 | 2015 | 3080 | 0.050 |
Why?
|
Veins | 1 | 2005 | 768 | 0.050 |
Why?
|
Algorithms | 2 | 2016 | 14154 | 0.050 |
Why?
|
Prostaglandins | 1 | 2022 | 398 | 0.050 |
Why?
|
Blood Pressure | 2 | 2015 | 8541 | 0.050 |
Why?
|
Palliative Care | 1 | 2016 | 3643 | 0.050 |
Why?
|
Cryosurgery | 1 | 2006 | 477 | 0.050 |
Why?
|
Physicians, Family | 1 | 2003 | 349 | 0.040 |
Why?
|
Heart Transplantation | 1 | 2014 | 3300 | 0.040 |
Why?
|
Recovery of Function | 1 | 2011 | 2990 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2012 | 5538 | 0.040 |
Why?
|
United States | 7 | 2020 | 73150 | 0.040 |
Why?
|
Action Potentials | 2 | 2020 | 1838 | 0.040 |
Why?
|
Catheters | 1 | 2023 | 427 | 0.040 |
Why?
|
Cerebral Cortex | 1 | 2016 | 5831 | 0.040 |
Why?
|
Prognosis | 7 | 2020 | 30022 | 0.040 |
Why?
|
Genetic Testing | 2 | 2020 | 3587 | 0.040 |
Why?
|
Syndrome | 1 | 2005 | 3275 | 0.040 |
Why?
|
Electric Stimulation | 1 | 2004 | 1743 | 0.040 |
Why?
|
Middle Aged | 19 | 2014 | 223491 | 0.040 |
Why?
|
North America | 2 | 2018 | 1290 | 0.040 |
Why?
|
Ambulatory Care | 2 | 2016 | 2784 | 0.040 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2024 | 856 | 0.040 |
Why?
|
California | 1 | 2002 | 1443 | 0.040 |
Why?
|
Fetal Death | 1 | 2020 | 438 | 0.040 |
Why?
|
Age Distribution | 1 | 2004 | 2877 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5375 | 0.040 |
Why?
|
Vascular Diseases | 1 | 2006 | 1161 | 0.040 |
Why?
|
Maternal-Fetal Exchange | 1 | 2020 | 462 | 0.040 |
Why?
|
Treatment Failure | 1 | 2004 | 2663 | 0.040 |
Why?
|
Homeostasis | 1 | 2008 | 3349 | 0.040 |
Why?
|
Reproducibility of Results | 5 | 2018 | 20224 | 0.030 |
Why?
|
Longitudinal Studies | 3 | 2015 | 14784 | 0.030 |
Why?
|
Seasons | 1 | 2002 | 1526 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2024 | 22296 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2005 | 2593 | 0.030 |
Why?
|
Observer Variation | 2 | 2018 | 2623 | 0.030 |
Why?
|
Preoperative Care | 2 | 2014 | 2258 | 0.030 |
Why?
|
District of Columbia | 1 | 2015 | 159 | 0.030 |
Why?
|
Hypesthesia | 1 | 2015 | 106 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10776 | 0.030 |
Why?
|
Fetal Mortality | 1 | 2014 | 19 | 0.030 |
Why?
|
Hospitals, Pediatric | 2 | 2015 | 1876 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2226 | 0.030 |
Why?
|
Linear Models | 2 | 2015 | 5878 | 0.030 |
Why?
|
Postoperative Care | 1 | 2020 | 1480 | 0.030 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2014 | 153 | 0.030 |
Why?
|
Differential Threshold | 1 | 2012 | 80 | 0.030 |
Why?
|
New England | 1 | 2016 | 1058 | 0.030 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 2012 | 97 | 0.030 |
Why?
|
Models, Biological | 1 | 2008 | 9493 | 0.020 |
Why?
|
Medical History Taking | 1 | 2016 | 776 | 0.020 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2012 | 146 | 0.020 |
Why?
|
Ultrasonography, Prenatal | 1 | 2020 | 1767 | 0.020 |
Why?
|
Rhabdomyoma | 1 | 2011 | 56 | 0.020 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2013 | 262 | 0.020 |
Why?
|
Postmortem Changes | 1 | 2011 | 119 | 0.020 |
Why?
|
Myxoma | 1 | 2011 | 114 | 0.020 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2016 | 752 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2002 | 2588 | 0.020 |
Why?
|
Gestational Age | 1 | 2020 | 3615 | 0.020 |
Why?
|
Propanolamines | 1 | 2011 | 164 | 0.020 |
Why?
|
Guideline Adherence | 2 | 2016 | 2240 | 0.020 |
Why?
|
Disease-Free Survival | 2 | 2015 | 6856 | 0.020 |
Why?
|
Hospital Mortality | 2 | 2015 | 5367 | 0.020 |
Why?
|
Cross-Over Studies | 2 | 2008 | 2106 | 0.020 |
Why?
|
Insurance, Health | 1 | 2002 | 2518 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2012 | 462 | 0.020 |
Why?
|
Fibroma | 1 | 2011 | 201 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 26375 | 0.020 |
Why?
|
Edema | 1 | 2014 | 766 | 0.020 |
Why?
|
Databases, Factual | 2 | 2015 | 8075 | 0.020 |
Why?
|
Physical Examination | 1 | 2016 | 1262 | 0.020 |
Why?
|
Electrophysiology | 1 | 2012 | 1266 | 0.020 |
Why?
|
Carbazoles | 1 | 2011 | 221 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2661 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2013 | 8562 | 0.020 |
Why?
|
Equipment Design | 2 | 2008 | 3529 | 0.020 |
Why?
|
Infant Mortality | 1 | 2014 | 757 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2012 | 633 | 0.020 |
Why?
|
Internationality | 1 | 2014 | 1008 | 0.020 |
Why?
|
Anesthetics, Local | 1 | 2015 | 1004 | 0.020 |
Why?
|
Evidence-Based Medicine | 2 | 2012 | 3707 | 0.020 |
Why?
|
Health Promotion | 1 | 2020 | 2209 | 0.020 |
Why?
|
Vital Capacity | 1 | 2011 | 984 | 0.020 |
Why?
|
Cardiotonic Agents | 1 | 2011 | 544 | 0.020 |
Why?
|
Health Planning Guidelines | 1 | 2008 | 153 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2011 | 1585 | 0.020 |
Why?
|
Spleen | 1 | 2014 | 2296 | 0.020 |
Why?
|
Spirometry | 1 | 2011 | 928 | 0.020 |
Why?
|
Medication Therapy Management | 1 | 2008 | 131 | 0.020 |
Why?
|
Europe | 1 | 2014 | 3439 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2018 | 8199 | 0.020 |
Why?
|
Program Evaluation | 1 | 2016 | 2505 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15939 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12092 | 0.020 |
Why?
|
Prenatal Diagnosis | 1 | 2014 | 1274 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2015 | 12456 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2018 | 1882 | 0.020 |
Why?
|
Length of Stay | 1 | 2020 | 6519 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 36849 | 0.020 |
Why?
|
Forced Expiratory Volume | 1 | 2011 | 1820 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 3836 | 0.020 |
Why?
|
Registries | 2 | 2015 | 8379 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2006 | 6241 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6318 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2012 | 1735 | 0.020 |
Why?
|
Pregnancy | 2 | 2020 | 30200 | 0.020 |
Why?
|
Phlebography | 1 | 2006 | 326 | 0.020 |
Why?
|
Pain Measurement | 1 | 2015 | 3581 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3813 | 0.010 |
Why?
|
Fibrosis | 1 | 2012 | 2077 | 0.010 |
Why?
|
Sex Factors | 1 | 2018 | 10654 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6510 | 0.010 |
Why?
|
Infant, Premature | 1 | 2014 | 2124 | 0.010 |
Why?
|
Therapeutic Irrigation | 1 | 2005 | 297 | 0.010 |
Why?
|
American Heart Association | 1 | 2008 | 1051 | 0.010 |
Why?
|
Atrioventricular Node | 1 | 2004 | 180 | 0.010 |
Why?
|
Body Size | 1 | 2006 | 463 | 0.010 |
Why?
|
Acute Disease | 1 | 2013 | 7242 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2014 | 2961 | 0.010 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2011 | 1766 | 0.010 |
Why?
|
Neural Conduction | 1 | 2004 | 443 | 0.010 |
Why?
|
Societies, Medical | 1 | 2014 | 3960 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16721 | 0.010 |
Why?
|
Blotting, Western | 1 | 2009 | 5037 | 0.010 |
Why?
|
Cold Temperature | 1 | 2005 | 786 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2742 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2002 | 11516 | 0.010 |
Why?
|
Aged | 5 | 2008 | 171562 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6541 | 0.010 |
Why?
|
Coronary Artery Disease | 2 | 2012 | 6567 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3541 | 0.010 |
Why?
|
United States Food and Drug Administration | 1 | 2008 | 1672 | 0.010 |
Why?
|
Ultrasonography | 1 | 2013 | 6001 | 0.010 |
Why?
|
Pilot Projects | 1 | 2012 | 8731 | 0.010 |
Why?
|
Computer Simulation | 1 | 2012 | 6277 | 0.010 |
Why?
|
Radiography | 1 | 2009 | 6993 | 0.010 |
Why?
|
Child Welfare | 1 | 2002 | 523 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 18048 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2008 | 5313 | 0.010 |
Why?
|
Cardiovascular Agents | 1 | 2003 | 849 | 0.010 |
Why?
|
Brain | 1 | 2022 | 27454 | 0.010 |
Why?
|
Genotype | 1 | 2008 | 13042 | 0.010 |
Why?
|
Lung | 1 | 2011 | 10089 | 0.010 |
Why?
|
Disease Progression | 1 | 2008 | 13646 | 0.010 |
Why?
|
Animals | 1 | 2018 | 169337 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2003 | 59686 | 0.000 |
Why?
|